Vgenomics - About the company
Vgenomics is a seed company based in Noida (India), founded in 2021 by Rahila Sardar and Preeti Gupta Lal. It operates as a Developer of diagnostic and therapeutic solutions for inborn diseases. Vgenomics has raised an undisclosed amount in funding from Mumbai Angels and O2 Angels Network, with a current valuation of ₹*****. The company has 599 active competitors, including 66 funded and 61 that have exited. Its top competitors include companies like BGI, Tessera Therapeutics and Hexagon Bio.
Company Details
Developer of diagnostic and therapeutic solutions for inborn diseases. It offers a comprehensive blood test and therapeutic solutions for rare inborn diseases. It also offer precise whole exome sequencing, RNAseq, and bioinformatics analysis services.
- Website
- vgenomics.in
- Email ID
- *****@vgenomics.co.in
- Phone Number
- +91 **********
- Registered Address
- Flat no. 156C, LIG PKT-12, Jasola, South Delhi, Delhi, Delhi, India, 110025
Key Metrics
Founded Year
2021
Location
Noida, India
Stage
Seed
Latest Funding Round
Post Money Valuation
₹***** as on Dec 18, 2023
Investors
Ranked
60th among 599 active competitors
Annual Revenue
0 - ₹10 Cr as on Mar 31, 2025
Employee Count
13 as on May 31, 2026
Similar Companies
Legal entities associated with Vgenomics
Vgenomics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
VGENOMICS INDIA PRIVATE LIMITED CIN: U85300DL2022PTC397081 , India, Active | Apr 21, 2022 | 0 - ₹10 Cr (As on Mar 31, 2025) | - |
Sign up to download Vgenomics' company profile
Vgenomics's funding and investors
Vgenomics has raised funding over 1 round. Its latest funding round was a Seed round on Jan 16, 2024 for $*****. 4 investors participated in its latest round. Vgenomics has 3 institutional investors and 2 angel investors.
Here is the list of recent funding rounds of Vgenomics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 16, 2024 | 6946397 | Seed | 3135806 | 6647627 | 8995105 | 5786558 |
View details of Vgenomics's funding rounds and investors
Vgenomics' founders and board of directors
Founder? Claim ProfileThe founders of Vgenomics are Rahila Sardar and Preeti Gupta Lal. Rahila Sardar is the CEO of Vgenomics.
Here are the details of Vgenomics' key team members:
- Rahila Sardar: Co-Founder & CEO of Vgenomics. They serve on the board of 1 company.
- Preeti Gupta Lal: Co-Founder & CSO of Vgenomics. They serve on the board of 1 company.
Vgenomics' Board of Directors
Vgenomics's board has 2 active members. Rahila Sardar and Preeti Gupta Lal are part of team.Here is the list of Vgenomics' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 4y 4m | |
Team | - | Current | 4y 0m |
View details of Vgenomics's Founder profiles and Board Members
Vgenomics' employee count trend
Vgenomics has 13 employees as of May 26. Here is Vgenomics's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Vgenomics's Competitors and alternates
Top competitors of Vgenomics include BGI, Tessera Therapeutics and Hexagon Bio. Here is the list of Top 10 competitors of Vgenomics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of services in genome sequencing | - | 64/100 | ||
2nd | Tessera Therapeutics 2017, Cambridge (United States), Series C | Provider of new genome engineering technology for treating multiple diseases | $610M | 63/100 | |
3rd | Hexagon Bio 2017, Menlo Park (United States), Series B | Provider of bioinformatics tools for the analysis of microbial genomic sequencing data | $206M | 62/100 | |
4th | Cellanome 2020, Palo Alto (United States), Series B | Developer of the omic data platform for researchers | $119M | 59/100 | |
5th | Novogene Corporation 2011, Beijing (China), Series B | Provider of genomic services and solutions | $75M | 59/100 | |
6th | Replay 2021, San Diego (United States), Acquired | Provider of genomic reprogramming platform for writing and delivering big DNA | $55M | 58/100 | |
7th | Baebies 2013, Durham (United States), Series C | Provider of diagnostic products for pediatrics | $95.9M | 58/100 | |
8th | Provider of bioinformatics tools for the analysis of genome sequencing data | $48.8M | 57/100 | ||
9th | Singular Genomics 2016, San Diego (United States), Acquired | Provider of next-generation gene sequencing and multi-omics technologies | - | 57/100 | |
10th | Developer of orphan drugs for treatment and diagnostics solutions | $6.92M | 55/100 | ||
60th | Developer of diagnostic and therapeutic solutions for inborn diseases | - | 37/100 |
Looking for more details on Vgenomics's competitors? Click here to see the top ones
Vgenomics's Investments and acquisitions
Vgenomics has made no investments or acquisitions yet.
Reports related to Vgenomics
Here is the latest report on Vgenomics's sector:
News related to Vgenomics
•
Vgenomics, Meril Genomics Collaborate To Revolutionise Precision MedicineIndiaMedToday•Apr 22, 2025•Vgenomics, Meril
•
Vgenomics & Meril Genomics Partner to Revolutionize Precision Medicine in IndiaBioSpectrum India•Apr 22, 2025•Vgenomics, Meril
•
Vgenomics & Meril Genomics Partner to Advance Precision Medicine in IndiaBioSpectrum India•Apr 22, 2025•Vgenomics
•
•
Vgenomics Secures Seed Funding for Biotech AdvancementsStartup Story•Jan 16, 2024•Vgenomics, Mumbai Angels, O2 Angels Network
Are you a Founder ?
FAQs about Vgenomics
Explore our recently published companies
- M.F. Smith Contracting - Unfunded company
- Rebel Mosquito - Unfunded company
- Miloy - United Kingdom based, 2023 founded, Unfunded company
- Blue Bonnet - Tyler based, Unfunded company
- Preparing Places - Unfunded company
- Hello Lemon - 2021 founded, Unfunded company